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Abstract
Background: Periprosthetic joint infections are mainly caused by Gram-positive cocci. Leuconostoc mesenteroides is
a rare microorganism mainly causing bloodstream infections. At times, it might be confused with another type of
cocci and give rise to misdiagnosed infections. Molecular diagnosis and biofilm production comprise important
techniques to guide antibiotic treatment.
Case presentation: A 68-year-old Hispanic female with a previous history of bilateral knee arthroplasty presented
with acute right-knee inflammation and gait impairment. Blood tests showed inflammatory response and knee x-ray
revealed no prosthesis loosening. Irrigation and debridement was performed. Gram-positive cocci were obtained
from cultures, and then biochemical and molecular identification revealed L. mesenteroides. Susceptibility and
biofilm production were performed. The patient was treated with IntraVenous (IV) Ceftriaxone for ten days and was
then switched to Amoxicillin-Clavulanate for 3 months with clinical and laboratory success.
Conclusions: Microbiology diagnosis of fastidious microorganisms is mandatory to treat periprosthetic joint
infections adequately. L. mesenteroides may infect non-immunocompromised persons; however, treatment
guidelines are lacking.
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Background
Leuconostoc species are Gram-positive microorganisms
with coccoid morphology and catalase-negative reaction
[1]. Leuconostoc spp. have been involved in a variety of
infections [2–7], particularly in patients being treated with
Vancomycin and in immunocompromised patients; in
addition, they have also been documented in outbreaks
[8]. Species within this genus are not easily identified in
clinical microbiology laboratories, with clinical isolates
sometimes being reported incorrectly as Enterococcus
species or Streptococcus species by routine biochemical
testing. The distinction among these different bacteria may
exert an important impact in selecting the appropriate
antibiotic regimen for the patient’s treatment, because all
clinical isolates of Leuconostoc spp. possess high-level
resistance to Vancomycin, with a Minimal Inhibitory
Concentration (MIC) >256 μg/mL [9].
Prosthetic Joint Infections (PJI) comprise a significant
part of acute and chronic infections in many hospitals and
are related with clinical and social problems, such as pro-
longed hospitalization and frequent, additional surgical
procedures, which are associated with an increased risk of
hospital complications and prolonged antimicrobial treat-
ment [10, 11]. These infections are principally linked with
the surgical procedure or with an infection either near to
the prosthesis or elsewhere. Germs that commonly infect
these devices are those belonging to the genus Staphylo-
coccus. Moreover, a wide range of bacteria responsible for
PJI is able to produce biofilm on prosthetic implants.
Biofilm is a complex microbial environment protected by
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a self-produced polymeric matrix and it adheres to various
surfaces [12]. Its formation notably hinders sampling and
culturing, because traditional sampling techniques are not
able to detach biofilm-embedded bacteria from prosthetic
surfaces, thus leading to negative results [13]. There are
clinical guidelines for treating this type of infections; these
recommend debridement and retention strategy in patients
with fewer than 3 weeks of symptoms onset [14]. Patients
who do not comply with this criterion should undergo a
single-stage or 2-stage exchange strategy depending on
their clinical condition and should receive antibiotic
therapy according to antimicrobial susceptibility.
To date, a periprosthetic joint infection caused by L.
mesenteroides, to our knowledge, has yet to be described.
Case presentation
A 68-year-old Hispanic female, with a previous diagnosis
of arterial hypertension on Enalapril treatment, obesity
with BMI of 35 and bilateral knee osteoarthritis. The
patient received left primary total knee arthroplasty in
December 2008, and right primary total knee arthroplasty
in March 2010. She had an upper respiratory tract infec-
tion 3 weeks prior to hospital admission without receiving
any antibiotic therapy. She debuted in March 2013 with
right knee erythema, edema, local hyperthermia, and
increasing pain on engaging in any type of movement. On
admission, the patient had a fever of 38.2 °C, blood
pressure of 110/80 mmHg, and a pulse rate of 96 beats/
min, she denied taking antibiotics or having food poiso-
ning previously. Laboratory examinations revealed a
hemoglobin level of 14.5 g/dL, a platelet count of 281,000/
lL, and a white-cell count of 25,400/lL, and C-Reactive
Protein (CRP) of 65 mg/dL (0–6 mg/dL). A plain knee
radiograph showed gas absence or prosthesis loosening
(Fig. 1). Arthrocentesis puncture was performed and
Gram-positive cocci were seen; however the cell count
could not be performed because the sample coagulated.
Surgical debridement was performed, finding the presence
of pus and necrotic tissue at vastus medialis; as well as
curettage to obtain bloody weaving and properly
consistency at the periphery of the prosthesis, which did
not present loosening. Once observed revitalized tissue,
three litters of saline solution with gentamicine were
irrigated. The liner was changed. Three samples of
periprosthetic tissue were obtained and transported
immediately to the laboratory. All samples showed Gram-
positive cocci in the initial Gram stain. The biopsy speci-
mens were inoculated in conventional culture media and,
after 24 h, there was the growth of an organism. The
colonies were white, raised, and small on 5% sheep blood
agar (Fig. 2). Identification was carried out using the
VITEK®2 (bioMérieux, Marcy L’Etoile, France) system,
which yielded the result of a L. mesenteroides. Biochemical
tests were performed as recommended in the literature
[15]; briefly, we conducted confirmation of resistance to
Vancomycin on Mueller–Hinton agar; gas production was
observed from glucose, which did not grow in bile esculin
media and which presented arabinose and mannitol
assimilation. The broth microdilution susceptibility assay
was carried out in Mueller–Hinton agar with lysed horse
blood employing the American Type Culture Collection
(ATCC) strain 29,213 as positive control; the latter
exhibited susceptibility to Penicillin and Ampicillin with
MIC 0.062 μg/mL and 0.5 μg/mL, respectively. 16S re-
combinant RNA (rRNA) gene sequencing was performed
on bacterial cultures. DNA was extracted using the
QIAmp DNA Minikit method (Qiagen, Ltd., West Sussex,
UK) according to the manufacturer’s instructions. Ampli-
fication of the bacterial 16S rRNA gene was performed by
real-time PCR in a Light-Cycler instrument (Roche
Diagnostics, Mannheim, Germany). The DNA sequence
was determined with a sequence analyzer (ABI PRISM
3130xL; Applied Biosystems) employing the same primers
as those with the BigDye kit (Applied Biosystems). The
a b
Fig. 1 Preoperative x-ray images of the a) lateral and b) AnteroPosterior (AP) view of the right knee showing prosthesis without loosening
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sequences obtained were compared with bacterial se-
quences in the GenBank database utilizing the BLAST
program. This analysis demonstrated the microorganism
as L. mesenteroides. (GenBank: KU517836).1 We evalu-
ated biofilm production by carrying out the Christensen
method, revealing a mild level of biofilm production [16].
The patient received treatment with Ceftriaxone 2 g
OD for 10 days IntraVenously (IV) due to the lack of a
supply of Ampicillin at the time, and was then switched
to oral Amoxicillin-Clavulanate 875/125 mg tid for
3 months, when the patient had not knee symptoms and
CRP reached 5 mg/dL, without having any side adverse
events. Physical therapy was administered for 2 months,
with the patient regaining leg strength. Clinical and
laboratory evolution was good at 6-month time lapses
for 3 years without the presentation of inflammatory
knee symptoms and with CRP levels of 3 mg/dL.
Discussion
We present here a case of acute hematogenous infection
of knee prosthesis associated with L. mesenteroides
3 years after implantation. The patient’s main symptoms
were knee pain and fever. The origin of this microorga-
nism might be the patient’s previous upper respiratory
tract infection, which caused hyperpermeability, and the
subsequent bacterial entrance into the bloodstream. The
microorganism grew in all samples obtained, indicating
a high bacterial content in the tissues and on the device.
L. mesenteroides is a Gram-positive cocci that is a non-
producer of catalase reaction, which is sometimes
misinterpreted with members of the Streptococcus genus.
It is widely distributed in nature. At the industrial level,
it is used in the production of wines, cheeses, dairy
products, and sugar. Infections have been commonly
described in patients with immunosuppression and in
patients in the Intensive Care Unit (ICU), causing blood-
stream infections.
Conventional identification in the laboratory is complex;
thus, the use of biochemical and molecular biology
techniques is worthwhile to assure a proper diagnosis.
Importantly, this genus is intrinsically resistant to Vanco-
mycin associated with chromosomal resistance; therefore,
beta-lactams are the preferred antimicrobial to treat this
type of infections, e.g., Ampicillin. The patient received
Ceftriaxone IV as the first part of the treatment during
the 10-day hospital stay, and was then switched to
Amoxicillin-Clavulanate for 3 months, the patient exhi-
biting good tolerance, compliance and complete func-
tional articular recovery.
Although this Leuconostoc strain demonstrated biofilm
production, it was classified as a mild biofilm producer.
Leathers et al. compared different strains of L. mesenter-
oides and found that the biofilm formation capacity var-
ied widely between the strains, and that this ability is
related with the amount of its components [17]. There
are, to our knowledge, no studies evaluating the activity
of Amoxicillin-Clavulanate properties against biofilm
production in L. mesenteroides; however, in other genera,
such as Staphylococcus spp., it does not possess activity
[18]. The patient did not receive any other drug against
biofilm production and, for the 3-year follow-up period,
there has not been an infection relapse.
According to the Practice Guidelines of the Infectious
Disease Society of America (IDSA) the recommended
treatment is 2–6 weeks of pathogen-specific IV and
switching to highly bioavailable oral antimicrobial ther-
apy for 3 to 6 months, as well as monitoring for clinical
and laboratory response [14]. Amoxicillin-Clavulanate
has been considered an alternative antibiotic option in
these guidelines, and it should be prescribed three times
daily due to its bone pharmacokinetics properties [19].
Surgical debridement must be performed as soon as
possible in order to remove all damaged tissue, as was
carried out in this patient, because this patient presented
symptoms of fewer than 3 weeks and sought attention
soon after the device was retained, as suggested.
This case is interesting and useful first because every
PJI is important for identifying and for ruling out when
it presents acutely in a previously asymptomatic patient,
in that surgical debridement is a crucial measure for
successfully retaining the device in order to cleanse the
periprosthetic tissue and to take samples of different
tissues to identify the causing microorganism. The
patient did not receive any type of medical care while
a b
Fig. 2 a) Gram stain showing Gram positive cocci. b) Typical white and small bacteria colonies on 5% sheep blood agar
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she experienced the upper respiratory tract infection; thus,
it is important to seek medical evaluation if a patient
complains of gastrointestinal, urinary, or respiratory infec-
tious symptoms and if the patient has a joint device. The
oral antibiotic therapy duration lasted until she was
symptoms-free and the CRP reached normal values, as it
is suggested for microorganisms different to Staphylococci
[14]. Second, as in many other diseases, multidisciplinary
collaboration is an essential part of the care of these types
of infections. Therefore, it is recommended that PJI be
treated at referral hospitals that have all of the services
needed, even in low-income countries.
Third, adequate microbial identification is required to
provide proper treatment during hospitalization and
afterward. Semi-automatized laboratory equipment is
helpful in the vast majority of strains, as was observed in
this case. However, it is strongly suggested to confirm
the diagnosis by another method in order to assure
identification and to perform the suitable susceptibility
tests, especially cases of fastidious microorganisms,
which as in the present case. The knowledge of some
microbial features, such as biofilm-production intensity,
may afford more information concerning possible treat-
ment success or the addition of another drug against its
formation.
This is, to our knowledge, the first report of a Pros-
thetic Joint Infection (PJI) in an immunocompetent pa-
tient that was caused by L. mesenteroides with successful
treatment.
Conclusion
We present a case of a Leuconostoc mesenteroides peri-
prosthetic knee infection in an immunocompetent woman.
An accurate diagnosis is mandatory to avoid antibiotic
mistreatment. Debridement surgery and antimicrobial
therapy are the pillars of high success in acute PJI. It is
highly recommended that patients with symptoms sug-
gesting infection elsewhere seek care in order to decrease
the possibilities of infectious prosthetic complications. To
date, there are, to our knowledge, no guidelines for treat-
ment that have been described in this type of bacterial
infections.
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